A detailed history of Balyasny Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 99,300 shares of ABBV stock, worth $17.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
99,300
Previous 8,254 1103.05%
Holding current value
$17.9 Million
Previous $1.42 Million 1285.8%
% of portfolio
0.03%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $926,108 - $1.08 Million
-5,983 Reduced 42.02%
8,254 $1.42 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $9.55 Million - $10.9 Million
-59,775 Reduced 80.76%
14,237 $2.59 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $24.2 Million - $27.3 Million
-175,999 Reduced 70.4%
74,012 $11.5 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $61.9 Million - $71.6 Million
-463,248 Reduced 64.95%
250,011 $37.3 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $34.5 Million - $42.9 Million
260,079 Added 57.39%
713,259 $96.1 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $60.7 Million - $69.9 Million
-419,818 Reduced 48.09%
453,180 $72.2 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $97.1 Million - $116 Million
701,963 Added 410.42%
872,998 $141 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $22.1 Million - $25.4 Million
164,730 Added 2612.69%
171,035 $23 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $23 Million - $29.2 Million
-167,048 Reduced 96.36%
6,305 $966,000
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $26,132 - $32,422
-198 Reduced 0.11%
173,353 $28.1 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $16.4 Million - $20.7 Million
152,643 Added 730.07%
173,551 $23.5 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $2.22 Million - $2.53 Million
20,908 New
20,908 $2.26 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $5.24 Million - $6.15 Million
-61,000 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $38.6 Million - $51.7 Million
-526,189 Reduced 89.61%
61,000 $5.99 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $35.8 Million - $54.3 Million
555,525 Added 1754.44%
587,189 $44.7 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $2.28 Million - $2.86 Million
31,664 New
31,664 $2.8 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $2.95 Million - $3.55 Million
-46,884 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $2.19 Million - $2.8 Million
-33,372 Reduced 41.58%
46,884 $3.41 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $2.11 Million - $2.48 Million
27,297 Added 51.54%
80,256 $6.47 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $304,004 - $374,919
3,905 Added 7.96%
52,959 $4.88 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $3.4 Million - $3.78 Million
38,237 Added 353.49%
49,054 $4.64 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $38.6 Million - $45.6 Million
-429,683 Reduced 97.54%
10,817 $1 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $21.3 Million - $28.5 Million
231,273 Added 110.54%
440,500 $41.7 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $64.5 Million - $70.7 Million
-720,172 Reduced 77.49%
209,227 $20.2 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $64.9 Million - $82.9 Million
929,399
929,399 $82.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.